ReviewPflugers Archiv : European journal of physiology2026
Electroacupuncture as a therapeutic intervention for obesity: mechanisms and implications.
Review in Pflugers Archiv : European journal of physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Obesity, a prevalent metabolic disease characterized by chronic systemic inflammation and dysregulated energy homeostasis, contributes to comorbidities such as type 2 diabetes and non-alcoholic fatty liver disease. Despite advancements in lifestyle interventions, pharmacotherapy and bariatric surgery, limitations in efficacy and safety emphasize the necessity for alternative therapeutic interventions. Electroacupuncture (EA), a contemporary form of traditional acupuncture, has emerged as a promising non-invasive intervention for obesity. This review synthesizes current evidence on the neuroendocrine, immunomodulatory, and metabolic mechanisms through which EA modulates hypothalamic nuclei, gut-liver axis signaling, white adipose tissue browning, and sympathetic-immune interactions. Preclinical studies have highlighted the potential of EA to enhance satiety signals, restore gut microbiota balance, suppress inflammasome activity, and promote white adipose tissue browning. Future research needs to prioritize human studies, elucidate neural circuitry, and optimize treatment protocols to translate preclinical findings into clinical practice.
Indexed as
Identifiers
41501215What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.